Global Growth Hormone Injection Market Growth 2024-2030

Publication ID:

LPI07245064

Publication Date:

July 4, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Growth hormone injection is a drug used to promote human growth and development. The main ingredient is human growth hormone. It exerts its physiological functions by stimulating the liver and other tissues to produce insulin-like growth factor (IGF-1), promotes bone growth, protein synthesis, and affects fat and mineral metabolism, playing a key role in human growth and development.
The global Growth Hormone Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淕rowth Hormone Injection Industry Forecast鈥� looks at past sales and reviews total world Growth Hormone Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Growth Hormone Injection sales for 2024 through 2030. With Growth Hormone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Growth Hormone Injection industry.
This Insight Report provides a comprehensive analysis of the global Growth Hormone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Growth Hormone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Growth Hormone Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Growth Hormone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Growth Hormone Injection.
United States market for Growth Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Growth Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Growth Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Growth Hormone Injection players cover Novo Nordisk, Genentech, Eli Lily, Pfizer, Shree Venkatesh International Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Growth Hormone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long-acting Water Injection
Short-acting Water Injection
Short-acting Powder Injection
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Genentech
Eli Lily
Pfizer
Shree Venkatesh International Limited
LG Chem
Anhui Anke Biotechnology
Zhongshan Sinobioway Hygene Biomedicine
Shanghai United Cell Biotechnology
Changchun GeneScience Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Growth Hormone Injection market?
What factors are driving Growth Hormone Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Growth Hormone Injection market opportunities vary by end market size?
How does Growth Hormone Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Growth Hormone Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Growth Hormone Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Growth Hormone Injection by Country/Region, 2019, 2023 & 2030
2.2 Growth Hormone Injection Segment by Type
2.2.1 Long-acting Water Injection
2.2.2 Short-acting Water Injection
2.2.3 Short-acting Powder Injection
2.3 Growth Hormone Injection Sales by Type
2.3.1 Global Growth Hormone Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Growth Hormone Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Growth Hormone Injection Sale Price by Type (2019-2024)
2.4 Growth Hormone Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Growth Hormone Injection Sales by Application
2.5.1 Global Growth Hormone Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Growth Hormone Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Growth Hormone Injection Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Growth Hormone Injection Breakdown Data by Company
3.1.1 Global Growth Hormone Injection Annual Sales by Company (2019-2024)
3.1.2 Global Growth Hormone Injection Sales Market Share by Company (2019-2024)
3.2 Global Growth Hormone Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Growth Hormone Injection Revenue by Company (2019-2024)
3.2.2 Global Growth Hormone Injection Revenue Market Share by Company (2019-2024)
3.3 Global Growth Hormone Injection Sale Price by Company
3.4 Key Manufacturers Growth Hormone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Growth Hormone Injection Product Location Distribution
3.4.2 Players Growth Hormone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Growth Hormone Injection by Geographic Region
4.1 World Historic Growth Hormone Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Growth Hormone Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Growth Hormone Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Growth Hormone Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Growth Hormone Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Growth Hormone Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Growth Hormone Injection Sales Growth
4.4 APAC Growth Hormone Injection Sales Growth
4.5 Europe Growth Hormone Injection Sales Growth
4.6 Middle East & Africa Growth Hormone Injection Sales Growth
5 Americas
5.1 Americas Growth Hormone Injection Sales by Country
5.1.1 Americas Growth Hormone Injection Sales by Country (2019-2024)
5.1.2 Americas Growth Hormone Injection Revenue by Country (2019-2024)
5.2 Americas Growth Hormone Injection Sales by Type (2019-2024)
5.3 Americas Growth Hormone Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Growth Hormone Injection Sales by Region
6.1.1 APAC Growth Hormone Injection Sales by Region (2019-2024)
6.1.2 APAC Growth Hormone Injection Revenue by Region (2019-2024)
6.2 APAC Growth Hormone Injection Sales by Type (2019-2024)
6.3 APAC Growth Hormone Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Growth Hormone Injection by Country
7.1.1 Europe Growth Hormone Injection Sales by Country (2019-2024)
7.1.2 Europe Growth Hormone Injection Revenue by Country (2019-2024)
7.2 Europe Growth Hormone Injection Sales by Type (2019-2024)
7.3 Europe Growth Hormone Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Growth Hormone Injection by Country
8.1.1 Middle East & Africa Growth Hormone Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Growth Hormone Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Growth Hormone Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Growth Hormone Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Growth Hormone Injection
10.3 Manufacturing Process Analysis of Growth Hormone Injection
10.4 Industry Chain Structure of Growth Hormone Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Growth Hormone Injection Distributors
11.3 Growth Hormone Injection Customer
12 World Forecast Review for Growth Hormone Injection by Geographic Region
12.1 Global Growth Hormone Injection Market Size Forecast by Region
12.1.1 Global Growth Hormone Injection Forecast by Region (2025-2030)
12.1.2 Global Growth Hormone Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Growth Hormone Injection Forecast by Type (2025-2030)
12.7 Global Growth Hormone Injection Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Growth Hormone Injection Product Portfolios and Specifications
13.1.3 Novo Nordisk Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Genentech
13.2.1 Genentech Company Information
13.2.2 Genentech Growth Hormone Injection Product Portfolios and Specifications
13.2.3 Genentech Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Genentech Main Business Overview
13.2.5 Genentech Latest Developments
13.3 Eli Lily
13.3.1 Eli Lily Company Information
13.3.2 Eli Lily Growth Hormone Injection Product Portfolios and Specifications
13.3.3 Eli Lily Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Eli Lily Main Business Overview
13.3.5 Eli Lily Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Growth Hormone Injection Product Portfolios and Specifications
13.4.3 Pfizer Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Shree Venkatesh International Limited
13.5.1 Shree Venkatesh International Limited Company Information
13.5.2 Shree Venkatesh International Limited Growth Hormone Injection Product Portfolios and Specifications
13.5.3 Shree Venkatesh International Limited Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Shree Venkatesh International Limited Main Business Overview
13.5.5 Shree Venkatesh International Limited Latest Developments
13.6 LG Chem
13.6.1 LG Chem Company Information
13.6.2 LG Chem Growth Hormone Injection Product Portfolios and Specifications
13.6.3 LG Chem Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LG Chem Main Business Overview
13.6.5 LG Chem Latest Developments
13.7 Anhui Anke Biotechnology
13.7.1 Anhui Anke Biotechnology Company Information
13.7.2 Anhui Anke Biotechnology Growth Hormone Injection Product Portfolios and Specifications
13.7.3 Anhui Anke Biotechnology Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Anhui Anke Biotechnology Main Business Overview
13.7.5 Anhui Anke Biotechnology Latest Developments
13.8 Zhongshan Sinobioway Hygene Biomedicine
13.8.1 Zhongshan Sinobioway Hygene Biomedicine Company Information
13.8.2 Zhongshan Sinobioway Hygene Biomedicine Growth Hormone Injection Product Portfolios and Specifications
13.8.3 Zhongshan Sinobioway Hygene Biomedicine Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Zhongshan Sinobioway Hygene Biomedicine Main Business Overview
13.8.5 Zhongshan Sinobioway Hygene Biomedicine Latest Developments
13.9 Shanghai United Cell Biotechnology
13.9.1 Shanghai United Cell Biotechnology Company Information
13.9.2 Shanghai United Cell Biotechnology Growth Hormone Injection Product Portfolios and Specifications
13.9.3 Shanghai United Cell Biotechnology Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai United Cell Biotechnology Main Business Overview
13.9.5 Shanghai United Cell Biotechnology Latest Developments
13.10 Changchun GeneScience Pharmaceutical
13.10.1 Changchun GeneScience Pharmaceutical Company Information
13.10.2 Changchun GeneScience Pharmaceutical Growth Hormone Injection Product Portfolios and Specifications
13.10.3 Changchun GeneScience Pharmaceutical Growth Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Changchun GeneScience Pharmaceutical Main Business Overview
13.10.5 Changchun GeneScience Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂